More older women are retaining 'young' breasts causing potential screening problemsMarch 14, 2004Many of today's generation of postmenopausal women have breast tissue more akin to that of younger women. This makes it harder for mammograms to pick up tumours or early signs of breast cancer in some over 50s and may also lead to unnecessary biopsies because of uncertainty in reading the results, a meeting of screening specialists will hear today (Tuesday 16 March). Mammogram samples from a screening programme in the Netherlands showed that a quarter of women aged 50 to 69 had the 'dense'[1] mammographic breast patterns more normally associated with younger women. Among 50 to 54-year-olds the proportion was 44%. Radiologist Dr Fred van der Horst said no one really knew why the change had occurred. It was unlikely to be due entirely to HRT as its use never exceeded 15% in the Netherlands. But, it could partly be due to the changes in childbearing patterns. Dr van der Horst will be presenting the findings at the 4th European Breast Cancer Conference to a special meeting of the European Group for Breast Cancer Screening. He said that breast cancer screening in postmenopausal women is effective but cancers can still go undetected. High mammographic density partly accounted for these missed cancers. The study set out to see what impact breast density had on screening performance. Researchers chose a random sample of 2,000 from among the 54,500 women who are screened every two years in a screening programme. They classified the mammograms as dense if more than a quarter of the breast was composed of dense tissue. If less than a quarter of the breast comprised dense tissue the mammograms were classified as lucent[1]. They found that 25% of 50 to 69-year-olds overall had dense breasts - 44% of 50 to 54-year-olds reducing to 17% of 65 to 69-year-olds. They then calculated the ratio of screen-detected cancers to the total number of screen-detected cancers plus those cancers arising in the interval between screening, to estimate the sensitivity of the mammograms i.e. the ability of the mammogram to detect cancer accurately in those women that had it. In the dense group it was only 59% compared to 67% in the lucent group. Dr van der Horst, a radiologist in the National Training and Expert Centre for Breast Cancer Screening in Nijmegen, said the difference in sensitivity between the two groups indicated the size of the potential problem. "I don't think the problem of women referred on because of uncertainties over dense breasts is that big in the Netherlands as there is a low referral rate. But, if larger numbers of women are referred on, then the probability of referrals that turn out to be unnecessary in hindsight will increase, and the risk of unnecessary referral will be higher for those with dense breasts. "However, it is difficult to disentangle the factors that play a part in referral as the chance of having breast cancer diagnosed increases with age anyway while the lower incidence in younger women is in itself a reason for a mammogram having a less certain predictive value." Dr van der Horst said it was unlikely that HRT played more than a part in the fact that today's postmenopausal women had denser breasts than their counterparts 20 years ago. "In the study group HRT use was under 10% in the perimenopausal period (the few years leading up to the menopause) and almost non-existent in the eldest group. In the Netherlands generally, HRT use has never been more than 15%. We know that women who have given birth have more lucent breasts than childless women. It's possible that demographic changes such as women having fewer children than 30 years ago and having them at a later age may play a role." Can anything be done to improve screening detection in women with dense breast tissue? Dr van der Horst said there had been some research hinting that adding ultrasound to mammography could improve cancer detection in women with dense breasts, but there was not enough information to warrant its introduction on a large scale for screening purposes. There was a general consensus that in the under 50s there should be at most a year between screenings. It was possible that the current two-year screening interval for women between 50 and 55 was not optimal. However, more frequent screening in a population-based screening programme would influence cost-effectiveness and necessitate political choices. (ends) Abstract no: 18 (The European Group for Breast Cancer Screening meeting is from 09.00 to 17.00 hrs in Hall 1). Note: [1] Dense tissue is glandular and shows white on mammograms. Lucent tissue is fat and shows black. The difficulty with dense tissue is that the white areas on mammograms may conceal possible cancer. Ultrasound acts the opposite way, showing cancerous tissue as black. In general women's breast tissue becomes more lucent as they age, especially if the have had children, although the denser a woman's tissue is when she is young the longer it takes to become lucent. MW Communications |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||